Join us for a Special Deep-Dive into

Immunotherapy and Targeted Therapy in Esophageal Cancer

with some of the Nation’s Top Experts

Saturday, April 17th at 11 am Eastern

Learn about the Latest Research that Supports First-Line Immunotherapy for Patients with Esophageal Cancer from the Distinguished Panel we have invited to share their experience, including Lead Investigators of those studies

Daniel Catenacci, MD
Associate Professor, Department of Medicine, Section of Hematology & Oncology
Director, Interdisciplinary Gastrointestinal Oncology Program
Assistant Director, Translational Research, Comprehensive Cancer Center
University of Chicago Medical Center
Chicago, IL

Manish A. Shah, MD
Bartlett Family Professor of Gastrointestinal Oncology
Chief, Solid Tumor Oncology Service
Director, Gastrointestinal Oncology Program
Weill Cornell Medicine
Co-Director, Center for Advanced Digestive Care
New York Presbyterian Hospital
New York, New York

Ronan J. Kelly, MD, MBA
Chief of Oncology for the 10 Baylor Scott & White Health’s North Texas Cancer Centers
Director of Oncology
Charles A. Sammons Cancer Center
Baylor University Medical Center
Dallas, Texas